Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
12/14/2005 | CN1231461C Bicyclo [2.2.1] heptanes and related compounds |
12/14/2005 | CN1231460C Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof |
12/14/2005 | CN1231457C Substituted cycloheptaene and its preparation process and use |
12/13/2005 | US6974879 Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogs |
12/08/2005 | WO2005115971A1 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor |
12/08/2005 | WO2005097100A3 Antibacterial agents |
12/08/2005 | US20050272821 Levalbuterol hydrochloride Polymorph A |
12/08/2005 | US20050272815 Compounds and compositions for delivering active agents |
12/08/2005 | US20050272783 Amino acids with affinity for the alpha2delta-protein |
12/08/2005 | US20050272665 Synthesis of alpha-amino-beta-alkoxy-carboxylic acid esters |
12/07/2005 | EP1602368A2 Cdc25 phosphatase inhibitors |
12/07/2005 | EP1601641A2 Substituted anilide ligands for the thyroid receptor |
12/07/2005 | CN1704404A Tricyclic protein kinase inhibitors |
12/07/2005 | CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |
12/07/2005 | CN1230416C Pharmaceutical compounds |
12/06/2005 | US6972300 Compounds and compositions for delivering active agents |
12/06/2005 | US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
12/06/2005 | CA2303244C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
12/01/2005 | WO2005113487A2 Polyurea compositions and compounds for the preparation thereof |
12/01/2005 | WO2005113483A2 Levalbuterol hydrochloride polymorph a |
12/01/2005 | WO2005113482A1 Levalbuterol hydrochloride polymorph b |
12/01/2005 | WO2005113481A1 Preparation of levalbuterol hydrochloride |
12/01/2005 | WO2005113471A1 Method of labeling with isotope of oxygen |
12/01/2005 | WO2005112943A1 Topical cromolyn formulations |
12/01/2005 | US20050267216 suspending or forming a slurry of the R enantiomer of albuterol dibenzoyl tartrate complex in at least one solvent;adding hydrogen chloride in a C1-C4 alcohol to the suspension or slurry until levalbuterol hydrochloride Polymorph B is obtained |
12/01/2005 | US20050267208 Nordihydroguaiartic derivatives for use in treatment of tumors |
12/01/2005 | US20050267169 Watersoluble prodrugs of propofol |
12/01/2005 | CA2566747A1 Topical cromolyn formulations |
12/01/2005 | CA2566605A1 Polyurea compositions and compounds for the preparation thereof |
12/01/2005 | CA2565188A1 Compounds and compositions for delivering active agents |
12/01/2005 | CA2556921A1 Levalbuterol hydrochloride polymorph b |
12/01/2005 | CA2556920A1 Levalbuterol hydrochloride polymorph a |
12/01/2005 | CA2556904A1 Preparation of levalbuterol hydrochloride |
11/30/2005 | CN1703394A Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
11/30/2005 | CN1701814A F1K-1 is a receptor for vascular endothelial growth factor |
11/30/2005 | CN1229344C Farnesyl transferase inhibitors |
11/30/2005 | CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative |
11/30/2005 | CN1229332C Extraction process of 15N-L-phenylalanine |
11/30/2005 | CN1229330C N-arylating method using amino-acid as additives |
11/29/2005 | US6969768 Preparation of 4-haloalkylnicotinic esters |
11/29/2005 | CA2144476C Process for preparing aminoethylglycine |
11/24/2005 | WO2005110395A1 System and device for magnetic drug targeting with magnetic drug carrier particles |
11/24/2005 | WO2005092011A3 Mitotic kinesin inhibitors |
11/24/2005 | WO2005068643A3 Biochemical synthesis of 6-amino caproic acid |
11/24/2005 | US20050261372 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator |
11/24/2005 | US20050261368 N-(tert-butyl)-2-methoxy-2-(4-hydroxy-3-(hydroxymethyl)phen-1-yl)-ethanamine; reduced steps for synthesis while maximizing synthetic yield without sacrificing compound purity; adding D-dibenzoyltartaric acid to mixture of racemic salbutamol in methanol; crystallizing, recrystalling in second solvent |
11/24/2005 | US20050261318 Protein kinase inhibitors |
11/24/2005 | US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
11/24/2005 | US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger |
11/24/2005 | US20050260597 Transfection reagents |
11/23/2005 | CN1699325A A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt |
11/23/2005 | CN1228312C Process for synthesizing beta-amino acid using ketone as raw material |
11/22/2005 | CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them |
11/17/2005 | WO2005108347A2 Substituted enaminones, their derivatives and uses thereof |
11/17/2005 | WO2005108339A2 High yield and rapid syntheses methods for producing metallo-organic salts |
11/17/2005 | US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
11/17/2005 | US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
11/17/2005 | US20050256032 Polyoxyalkylene compound and method for making |
11/17/2005 | US20050255138 Active agent transport systems |
11/17/2005 | US20050253415 Vehicle and a vehicle door |
11/17/2005 | CA2565840A1 High yield and rapid syntheses methods for producing metallo-organic salts |
11/16/2005 | EP1594853A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof |
11/16/2005 | EP1594843A2 Method for producing an optically active tetrahydroquinoline |
11/16/2005 | EP1594492A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
11/16/2005 | EP1594480A1 Method to treat chronic heart failure and/or elevated cholesterol levels |
11/16/2005 | EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
11/16/2005 | EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
11/15/2005 | US6965040 Photogenerated reagents |
11/15/2005 | CA2379908C Preparation of metal complexes of amino acids obtained by hydrolysis of soy protein |
11/10/2005 | WO2005105730A2 Method of preparing an alcohol from a halogenoaromatic compound and an aldehyde |
11/10/2005 | WO2005041924A3 Administration of levodopa and carbidopa |
11/10/2005 | US20050250857 Gelling agents |
11/10/2005 | US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
11/10/2005 | US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof |
11/10/2005 | CA2649054A1 Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
11/09/2005 | EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity |
11/09/2005 | EP1592661A2 Cyclopropyl beta-amino acid derivatives |
11/09/2005 | EP1592657A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it |
11/09/2005 | EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
11/09/2005 | CN1694869A Substituted spirocyclic ketoenols |
11/09/2005 | CN1226275C Method for preparing dextrorotary phenylalanine by asymmetric conversion method |
11/09/2005 | CN1225972C Fungicidal compositions based on (N-phenylacetyl-N-2,6-xylyl) alaninate |
11/03/2005 | WO2005103280A1 Process for producing optically active 4-(n-protected amino)-1-alken-3-ol and process for producing therefrom 3-benzamido-2-hydroxycarboxylic acid or salt thereof |
11/03/2005 | WO2005102988A1 Method of separately collecting optically active amino acid amide and optically active amino acid |
11/03/2005 | WO2005102987A1 Process for the preparation of valsartan and precursors thereof |
11/03/2005 | WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
11/03/2005 | WO2005079541A3 Terephthalamide peptidomimetic compounds and methods |
11/03/2005 | WO2005069930A3 Asymmetric hydrogenation of alpha-amino carbonyl compounds |
11/03/2005 | US20050245762 Isolating chlorosuccinic acid by cooling to 10-20 degrees C. to effect precipitation, where the acid has been prepared by reacting a suspension of aspartic acid in demineralized water containing NaCl with NaNO2 and aqueous HCl; mother liquors from previous reactions may be used as partial substitutes |
11/03/2005 | US20050245616 Ketoamine tumor suppressor reactivators: 3-Acetoxy-2-(acetoxymethyl)-1-oxo-1-phenylpropan-2-ammonium chloride |
11/03/2005 | CA2563752A1 Compositions of allosteric hemoglobin modifiers and methods of making the same |
11/02/2005 | EP1257524B1 A process for the preparation of salts of l-carnitine and alkanoyl l-carnitine with mucic acid |
11/02/2005 | EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
11/02/2005 | EP1100443B1 Hair treatment preparation |
11/01/2005 | US6960355 Modified amino acid compounds useful in delivery of active agents |
10/27/2005 | WO2005100302A1 Solid state forms of (-)-(1r,2s)-2-amino-4-methylene-cyclopentanecarboxylic acid |
10/27/2005 | WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors |
10/27/2005 | WO2005100300A1 5-aminolevulinic acid salt, process for producing the same and use thereof |
10/27/2005 | WO2005100298A1 Cetp inhibitors |
10/27/2005 | WO2005100297A1 Indene derivatives and process for the preparation thereof |